AFFERENT PHARMACEUTICALS, INC.

Profile

Company Names

AFFERENT PHARMACEUTICALS, INC.

Addresses

2929 CAMPUS DRIVE, SUITE 230, SAN MATEO, CA 94403

C/O THIRD ROCK VENTURES, L.P., 29 NEWBURY STREET, BOSTON, MA 02116

THIRD ROCK VENTURES, L.P., 29 NEWBURY STREET, BOSTON, MA 02116

Phone Numbers

650-286-1276
617-585-2000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER HEALTH CARE

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$58,149,986.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-07-01 
$54,999,986.00 
$54,999,986.00 
$0.00 
Equity 
2
2009-12-09 
$3,000,000.00 
$23,000,000.00 
$20,000,000.00 
Equity 
1
2009-10-23 
$150,000.00 
$150,000.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MITCHELL 
S. 
BLOOM 
EXECUTIVE OFFICER
AFFERENT PHARMACEUTICALS, INC.   |  ZAFGEN, INC.   |  CORIDEA NC1, INC.   |  NAUREX INC.   |  RANA THERAPEUTICS, INC.   |  VOYAGER THERAPEUTICS, INC.   |  AXON THERAPIES INC.
ANTHONY 
 
FORD 
EXECUTIVE OFFICER
AFFERENT PHARMACEUTICALS, INC.   |  AVALOR THERAPEUTICS, INC.
KATHLEEN 
SEREDA 
GLAUB 
EXECUTIVE OFFICER, DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  CURASEN THERAPEUTICS, INC.   |  ESCIENT PHARMACEUTICALS INC
PETER 
 
HIRTH 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  ALIOS BIOPHARMA INC   |  AFFERENT PHARMACEUTICALS, INC.   |  ICONIC THERAPEUTICS INC   |  SUTROVAX, INC.   |  ALIGOS THERAPEUTICS, INC.   |  ESCIENT PHARMACEUTICALS INC   |  TREX HOLDINGS INC.
MICHAEL 
 
KITT 
EXECUTIVE OFFICER
NUON THERAPEUTICS INC   |  AFFERENT PHARMACEUTICALS, INC.   |  ATTENUA, INC.   |  ESSEX STREET REIT INVESTOR (DE) LLC
DAVID 
 
NEAFUS 
EXECUTIVE OFFICER
SUSTAINX INC   |  AFFERENT PHARMACEUTICALS, INC.   |  PANGENX, INC.   |  MICROCHIPS BIOTECH, INC.   |  SYNDEVRX INC   |  ARRAKIS THERAPEUTICS, INC.   |  OBSIDIAN THERAPEUTICS, INC.   |  NAYAN THERAPEUTICS, INC.   |  AVILAR THERAPEUTICS, INC.   |  KERA THERAPEUTICS, INC.   |  SIGHTSTREAM BIOTHERAPEUTICS, INC.
ARTHUR 
 
PAPPAS 
DIRECTOR
CENERX BIOPHARMA INC   |  LEAD THERAPEUTICS, INC.   |  TYRX PHARMA INC   |  AFFERENT PHARMACEUTICALS, INC.   |  TYRX, INC.   |  BRAINCELLS INC   |  ASIA INNOVATION VENTURES, LP
LIAM 
 
RATCLIFFE 
DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  NEURONETICS, INC.   |  UNUM THERAPEUTICS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  NEW LEAF GROWTH FUND I, L.P.   |  APTINYX INC.   |  CURASEN THERAPEUTICS, INC.   |  ARVINAS, INC.   |  ELIEM THERAPEUTICS, INC.   |  HALDA THERAPEUTICS, LLC
KEVIN 
 
STARR 
EXECUTIVE OFFICER, DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  ZAFGEN, INC.   |  AGIOS PHARMACEUTICALS INC   |  PANOPTICA, INC.   |  MYOKARDIA INC   |  THIRD ROCK VENTURES III, L.P.   |  SAGE THERAPEUTICS, INC.   |  GLOBAL BLOOD THERAPEUTICS, INC.   |  DECIBEL THERAPEUTICS, INC.
JESSE 
 
TREU 
DIRECTOR
TANDEM DIABETES CARE INC   |  AFFERENT PHARMACEUTICALS, INC.   |  REGADO BIOSCIENCES INC   |  VERACYTE, INC.   |  ALTEA THERAPEUTICS CORP   |  RIGHTCARE SOLUTIONS, INC.   |  SEBACIA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-07-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-01 
2009-12-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-09 
2009-11-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2009-10-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#